ConductScience.org, home

Paper40940958

Prognostic Significance of PTEN Loss in Prostate Cancer: A Meta-Analysis of Gleason Grade and Clinical Outcomes.

Kisiel F and 6 others. Cancers (Basel), 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Prognostic Significance of PTEN Loss in Prostate Cancer: A Meta-Analysis of Gleason Grade and Clinical Outcomes. Papers, record 40940958. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40940958

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic Significance of PTEN Loss in Prostate Cancer: A Meta-Analysis of Gleason Grade and Clinical Outcomes.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.25, provisional
iCite
Revised in PubMed
2026-09-25
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kisiel FFiliphttps://orcid.org/0009-0008-6354-8053
2Ferguson DDougal
3Hart CClaire
4Brown MMickhttps://orcid.org/0000-0003-1322-4671
5Oliveira PPedro
6Sachdeva AAshwinhttps://orcid.org/0000-0002-7359-7114
7Gardner PPeter

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
EP/W00058X/1Engineering and Physical Sciences Research CouncilPubMed

Source PubMed

Download CSV of grants

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122266095PTEN in DNA damage repair.Cancer Lett2012https://conductscience.org/library/papers/22266095PubMed
226799286PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy.Oncotarget2016https://conductscience.org/library/papers/26799286PubMed
322705054Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer.Am J Pathol2012https://conductscience.org/library/papers/22705054PubMed
417700571FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.Br J Cancer2007https://conductscience.org/library/papers/17700571PubMed
529665325A gene signature associated with PTEN activation defines good prognosis intermediate risk prostate cancer cases.J Pathol Clin Res2018https://conductscience.org/library/papers/29665325PubMed
630782187Targeting PI3K in cancer: mechanisms and advances in clinical trials.Mol Cancer2019https://conductscience.org/library/papers/30782187PubMed
735869144Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer.Br J Cancer2022https://conductscience.org/library/papers/35869144PubMed
825946202Nuclear PTEN tumor-suppressor functions through maintaining heterochromatin structure.Cell Cycle2015https://conductscience.org/library/papers/25946202PubMed
938961192DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance.Br J Cancer2024https://conductscience.org/library/papers/38961192PubMed
1026612463Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer.Mod Pathol2016https://conductscience.org/library/papers/26612463PubMed
1126123120Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer.Prostate Cancer Prostatic Dis2016https://conductscience.org/library/papers/26123120PubMed
1229137428PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles.Oncotarget2017https://conductscience.org/library/papers/29137428PubMed
1321878536PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients.Clin Cancer Res2011https://conductscience.org/library/papers/21878536PubMed
1430279579PTEN status assessment in the Johns Hopkins active surveillance cohort.Prostate Cancer Prostatic Dis2019https://conductscience.org/library/papers/30279579PubMed
1527470558The association of Phosphatase and tensin homolog (PTEN) deletion and prostate cancer risk: A meta-analysis.Biomed Pharmacother2016https://conductscience.org/library/papers/27470558PubMed
1627693448PTEN Loss in Gleason Score 3 + 4 = 7 Prostate Biopsies is Associated with Nonorgan Confined Disease at Radical Prostatectomy.J Urol2017https://conductscience.org/library/papers/27693448PubMed
1731111513PTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcinoma).Prostate2019https://conductscience.org/library/papers/31111513PubMed
1827284364Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer.Oncol Lett2016https://conductscience.org/library/papers/27284364PubMed
1924054978The multiple layers of non-genetic regulation of PTEN tumour suppressor activity.Eur J Cancer2014https://conductscience.org/library/papers/24054978PubMed
2029460925Clinical implications of PTEN loss in prostate cancer.Nat Rev Urol2018https://conductscience.org/library/papers/29460925PubMed

See all 44 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42921139Prostate cancer: advancements in targeted therapies.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42921139PubMed
42901920Glutamine synthesis pathway promotes the survival and recurrence of dormant tumor cells in prostate cancer.Cell Death Discov2026https://conductscience.org/library/papers/42901920PubMed
42588694PTEN Protein Loss in Diagnostic Prostate Biopsies Is Associated with Gleason Score Upgrading in Radical Prostatectomy.Cancers (Basel)2026https://conductscience.org/library/papers/42588694PubMed
42586241Subclonal Complete Loss of CDKN1B as a Common Genomic Alteration in Prostate Cancer: Associations With Race and Prostate Cancer Outcomes.Mod Pathol2026https://conductscience.org/library/papers/42586241PubMed
42528594Genomic Determinants of Lethality and Therapeutic Vulnerability in Castration-Resistant Prostate Cancer.bioRxiv2026https://conductscience.org/library/papers/42528594PubMed
41762538From prostate specific antigen to genomic signatures: Advances in biomarkers for prostate cancer diagnosis and prognosis.Transl Oncol2026https://conductscience.org/library/papers/41762538PubMed
41750552Glyoxalase 2 Drives D-Lactate Oncometabolite Signaling to Promote Prostate Cancer Aggressiveness via FAK/Src Activation.Antioxidants (Basel)2026https://conductscience.org/library/papers/41750552PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354NCBI Gene
PTEN5728PubTator's text mininghttps://conductscience.org/library/genes/5728NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40940958

GET https://conductscience.org/api/papers/v1/40940958/references?page=2